Food effect study of Tofogliflozi

Phase 1

• Conditions: Type 2 diabetes

• Registration Number: JPRN-jRCT2080221804
• Lead Sponsor: Chugai Pharmaceutical Co., Ltd.

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-05-29
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Sex: Male
• Target Recruitment: 30

Inclusion Criteria

healthy volunteers
-Body mass index(BMI) >=18.5 kg/m2 and <25.0 kg/m2
-eGFR >=90 mL/min/1.73 m2
-Has not smoked for at least a year before screening and will not smoke during the study period

Exclusion Criteria

Has taken any of the medicines, foods and drinks that can affect the pharmacokinetics of Tofogliflozin within two weeks before administration in Period I.
Etc.

Study & Design

• Study Type: Interventional
• Study Design: Not specified